José Antonio
Pinto Tasende
Publicacións (34) Publicacións de José Antonio Pinto Tasende
2024
2023
-
Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis
Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 137-144
-
Defective chaperone-mediated autophagy is a hallmark of joint disease in patients with knee osteoarthritis
Osteoarthritis and Cartilage, Vol. 31, Núm. 7, pp. 919-933
-
Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain
Frontiers in Immunology, Vol. 14
-
Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis
BMC musculoskeletal disorders, Vol. 24, Núm. 1, pp. 246
-
Liver fibrosis 4 score: Use in the evaluation of non-alcoholic fatty liver disease in patients with psoriatic arthritis
Reumatologia Clinica, Vol. 19, Núm. 9, pp. 495-499
-
Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning
Journal of Clinical Medicine, Vol. 12, Núm. 3
-
The activity of psoriatic arthritis with axial involvement correlates with the PsAID12
Reumatologia Clinica
2022
-
Characteristics associated with the perception of high-impact disease (PsAID ≥4) in patients with recent-onset psoriatic arthritis. Machine learning-based model
Seminars in Arthritis and Rheumatism, Vol. 57
-
Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning
Arthritis research & therapy, Vol. 24, Núm. 1, pp. 153
-
Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning
Frontiers in Medicine, Vol. 9
2021
-
Epidemiological Characteristics and Adverse Events of Patients with Psoriatic Arthritis Undergoing Treatment with Biological Therapies in Galicia
Reumatologia Clinica, Vol. 17, Núm. 3, pp. 150-154
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
-
Secukinumab as Biological Treatment for Psoriatic Arthritis in Real Clinical Practice
Reumatologia Clinica, Vol. 17, Núm. 4, pp. 203-206
-
The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA–B27 Status?
Arthritis Care and Research, Vol. 73, Núm. 6, pp. 856-860
2020
-
Efficacy and Safety of Combined Therapy With Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Systematic Literature Review
Reumatologia Clinica, Vol. 16, Núm. 5P1, pp. 324-332
2019
-
Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project
Clinical and experimental rheumatology, Vol. 37, Núm. 5, pp. 731-739
-
Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257
2017
-
A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis
Rheumatology International, Vol. 37, Núm. 8, pp. 1347-1356
-
Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort
Arthritis Care and Research, Vol. 69, Núm. 6, pp. 938-942